美股市場個股詳情
VIR Vir Biotechnology
- 7.120
- +0.170+2.45%
收盤價 11/22 16:00 (美東)
- 7.120
- 0.0000.00%
盤後 20:01 (美東)
9.81億總市值-1811市盈率TTM
7.270最高價6.880最低價89.18萬股成交量7.000今開6.950昨收636.34萬成交額0.96%換手率虧損市盈率(靜)1.38億總股本13.09052周最高0.79市淨率6.59億流通值6.56052周最低--股息TTM9251.60萬流通股141.010歷史最高--股息率TTM5.61%振幅6.560歷史最低7.135平均價1股每手
關於Vir Biotechnology公司
Vir Biotechnology Inc 是一家免疫學公司，專注於結合尖端技術治療和預防嚴重傳染病和其他嚴重疾病，包括病毒相關疾病。通過內部開發、合作和收購，公司擁有四個技術平臺，專注於抗體、T細胞、先天免疫和小干擾核糖核酸(siRNA)。該公司的產品線包括針對乙型肝炎、乙型肝炎、甲型流感、人類免疫缺陷病毒、艾滋病毒和結核病(TB)的候選產品。公司的收入來源包括協作收入、合同收入、授權收入和許可收入。
公司介紹
公司代碼VIR
公司名稱Vir Biotechnology
上市日期2019/10/11
發行價格20.00
成立日期2016
CEODr. Marianne De Backer, PhD
所屬市場納斯達克
員工數量587
年結日12-31
公司地址1800 Owens Street,Suite 900
城市San Francisco
省份加利福尼亞州
國家美國
郵編94158
電話1-415-906-4324
董事高管
- 姓名
- 職務
- 年薪
- Dr. Marianne De Backer, PhD
- Chief Executive Officer and Director
- 3949.15萬
- Jennifer Towne
- Executive Vice President and Chief Scientific Officer
- --
- Jason O'Byrne
- Executive Vice President and Chief Financial Officer
- --
- Jeffrey Calcagno, M.D.
- Executive Vice President and Chief Business Officer
- 454.01萬
- Sasha Damouni Ellis
- Executive Vice President and Chief Corporate Affairs Officer
- --
- Brent Sabatini
- Senior Vice President and Chief Accounting Officer
- --
- Dr. Ann M. Hanly, PhD
- Executive Vice President and Chief Technology Officer
- 311.39萬
- Dr. Vicki L. Sato, PhD
- Chairman of the Board
- 48.82萬
- Dr. George A. Scangos,PhD
- Director
- 33.82萬
- Jeffrey S. Hatfield
- Independent Director
- 45.84萬
- Saira Ramasastry, M.Phil,M.S.
- Independent Director
- 45.99萬
- Janet Napolitano
- Independent Director
- 44.86萬
- Robert Taylor Nelsen
- Independent Director
- 44.49萬
- Dr. Elliott Sigal, M.D.,PhD
- Independent Director
- 46.24萬
- Professor Dr. Norbert W. Bischofberger, PhD
- Independent Director
- --
- Dr. Ramy Farid, PhD
- Independent Director
- --
- Robert J. More
- Independent Director
- 46.49萬
分析
目標價預測
暫無數據
熱議
美股
綜合熱度
股票代碼
最新價
升跌幅
暫無數據